The Shareholders’ Committee of Boehringer Ingelheim have announced the following appointments in the Shareholders’ Committee and the Board of Managing Directors...

NBE Therapeutics (NBE), a wholly owned subsidiary of  Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.

On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to...

Quantro Therapeutics, which focuses on transcription factors targeting cancer treatments, announced that it has reached a key milestone in its joint R&D program with...

The idea that statistics can address urgent sustainability concerns at the lab bench was central to presentations at the recent JMP Discovery Summit Europe in Manchester...

German drugmaker Boehringer Ingelheim is investing €120 million in an upgrade and expansion of its facility in Koropi, Greece, that will increase the company's capacity...

US biology company Ginkgo Bioworks has announced two separate partnerships, one on natural colors and dyes with Octarine Bio and the other on novel therapeutic molecules...

German biopharma Boehringer Ingelheim, compatriot CDMO Evotec and French diagnostics firm BioMérieux have formed a joint venture to develop a new approach to fight the...